SILDENAFIL CITRATE (sildenafil) by Aurobindo Pharma is phosphodiesterase 5 inhibitors [moa]. First approved in 2018.
Drug data last refreshed 21h ago
Phosphodiesterase 5 Inhibitors
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Sildenafil 100 mg Tablets Relative to Viagra 100 mg Tablets
A New Sildenafil Oral Film in Patients With Erectile Dysfunction
Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%
Effect of Sildenafil in Individuals With Migraine Pretreated With Erenumab
a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China
Worked on SILDENAFIL CITRATE at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.